BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9527064)

  • 1. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases.
    Sakamoto E; Nimura Y; Hayakawa N; Kamiya J; Kondo S; Nagino M; Kanai M; Miyachi M; Uesaka K
    Ann Surg; 1998 Mar; 227(3):405-11. PubMed ID: 9527064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma.
    Shimada H; Endo I; Fujii Y; Kunihiro O; Tanaka K; Misuta K; Togo S
    Hepatogastroenterology; 2002; 49(44):300-5. PubMed ID: 11995438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
    Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma.
    Shingu Y; Ebata T; Nishio H; Igami T; Shimoyama Y; Nagino M
    Surgery; 2010 Jan; 147(1):49-56. PubMed ID: 19767048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma.
    Ribero D; Amisano M; Lo Tesoriere R; Rosso S; Ferrero A; Capussotti L
    Ann Surg; 2011 Nov; 254(5):776-81; discussion 781-3. PubMed ID: 22042470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
    Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
    Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma.
    Jarnagin WR; Bowne W; Klimstra DS; Ben-Porat L; Roggin K; Cymes K; Fong Y; DeMatteo RP; D'Angelica M; Koea J; Blumgart LH
    Ann Surg; 2005 May; 241(5):703-12; discussion 712-4. PubMed ID: 15849506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.
    Su CH; Tsay SH; Wu CC; Shyr YM; King KL; Lee CH; Lui WY; Liu TJ; P'eng FK
    Ann Surg; 1996 Apr; 223(4):384-94. PubMed ID: 8633917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
    Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
    Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.
    Ebata T; Nagino M; Kamiya J; Uesaka K; Nagasaka T; Nimura Y
    Ann Surg; 2003 Nov; 238(5):720-7. PubMed ID: 14578735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic study of cholangiocarcinoma with superficial spread.
    Igami T; Nagino M; Oda K; Nishio H; Ebata T; Yokoyama Y; Shimoyama Y
    Ann Surg; 2009 Feb; 249(2):296-302. PubMed ID: 19212185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases.
    Ikeyama T; Nagino M; Oda K; Ebata T; Nishio H; Nimura Y
    Ann Surg; 2007 Dec; 246(6):1052-7. PubMed ID: 18043110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
    J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma.
    Endo I; House MG; Klimstra DS; Gönen M; D'Angelica M; Dematteo RP; Fong Y; Blumgart LH; Jarnagin WR
    Ann Surg Oncol; 2008 Aug; 15(8):2104-12. PubMed ID: 18543039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic cholangiocarcinoma presenting intrabile duct extension: clinicopathologic study of five resected cases.
    Yamamoto J; Kosuge T; Takayama T; Shimada K; Yamasaki S; Sakamoto M; Hirohashi S; Makuuchi M
    Jpn J Clin Oncol; 1997 Feb; 27(1):18-21. PubMed ID: 9070335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery for hilar cholangiocarcinoma: the Leeds experience.
    Hidalgo E; Asthana S; Nishio H; Wyatt J; Toogood GJ; Prasad KR; Lodge JP
    Eur J Surg Oncol; 2008 Jul; 34(7):787-94. PubMed ID: 18036765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
    Nakagohri T; Asano T; Kinoshita H; Kenmochi T; Urashima T; Miura F; Ochiai T
    World J Surg; 2003 Mar; 27(3):289-93. PubMed ID: 12607053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic cholangiocarcinoma presenting intrabile duct tumor growth: report of a case.
    Sano T; Yamamoto J; Kosuge T; Inoue K; Shimada K; Takayama T; Yamazaki S; Sakamoto M; Hirohashi S
    Hepatogastroenterology; 1996; 43(9):667-70. PubMed ID: 8799413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hilar resection in the treatment of hilar cholangiocarcinoma.
    Otani K; Chijiiwa K; Kai M; Ohuchida J; Nagano M; Kondo K
    Hepatogastroenterology; 2012 May; 59(115):696-700. PubMed ID: 22469711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.